SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the June 2024 quarter moved down to Rs. 168.10 millions as compared to Rs. 239.50 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -968.40 millions as compared to Net Loss of Rs. -953.50 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 further decreased to -935.60% as compared to -919.90% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 168.10 239.50 -29.81 168.10 239.50 -29.81 755.50 2387.80 -68.36
Other Income 15.60 101.90 -84.69 15.60 101.90 -84.69 294.70 108.80 170.86
PBIDT -935.60 -919.90 1.71 -935.60 -919.90 1.71 -3743.20 -2031.80 84.23
Interest 5.20 2.60 100.00 5.20 2.60 100.00 16.60 76.30 -78.24
PBDT -940.80 -922.50 1.98 -940.80 -922.50 1.98 -3759.80 -2108.10 78.35
Depreciation 27.60 31.00 -10.97 27.60 31.00 -10.97 121.30 117.70 3.06
PBT -968.40 -953.50 1.56 -968.40 -953.50 1.56 -3881.10 -2225.80 74.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -968.40 -953.50 1.56 -968.40 -953.50 1.56 -3881.10 -2225.80 74.37
Equity 324.50 324.50 0.00 324.50 324.50 0.00 324.50 324.50 0.00
PBIDTM(%) -556.57 -384.09 44.91 -556.57 -384.09 44.91 -495.46 -85.09 482.27

Sun Pharma Adv. Res Share Price

147.90 -4.25 (-2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×